[go: up one dir, main page]

HUE053974T2 - Szemészeti gyógyászati készítmény - Google Patents

Szemészeti gyógyászati készítmény

Info

Publication number
HUE053974T2
HUE053974T2 HUE16733411A HUE16733411A HUE053974T2 HU E053974 T2 HUE053974 T2 HU E053974T2 HU E16733411 A HUE16733411 A HU E16733411A HU E16733411 A HUE16733411 A HU E16733411A HU E053974 T2 HUE053974 T2 HU E053974T2
Authority
HU
Hungary
Prior art keywords
medicinal product
ophthalmic medicinal
ophthalmic
product
medicinal
Prior art date
Application number
HUE16733411A
Other languages
English (en)
Inventor
Hans Kalkbrenner
Original Assignee
Contipro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Contipro As filed Critical Contipro As
Publication of HUE053974T2 publication Critical patent/HUE053974T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/04Artificial tears; Irrigation solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HUE16733411A 2015-06-26 2016-06-24 Szemészeti gyógyászati készítmény HUE053974T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15173997.6A EP3108874A1 (en) 2015-06-26 2015-06-26 Ophthalmologic pharmaceutical composition

Publications (1)

Publication Number Publication Date
HUE053974T2 true HUE053974T2 (hu) 2021-07-28

Family

ID=53510642

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16733411A HUE053974T2 (hu) 2015-06-26 2016-06-24 Szemészeti gyógyászati készítmény

Country Status (12)

Country Link
US (1) US20180296473A1 (hu)
EP (2) EP3108874A1 (hu)
JP (1) JP6918711B2 (hu)
KR (1) KR20180021065A (hu)
DK (1) DK3313370T3 (hu)
ES (1) ES2864638T3 (hu)
HU (1) HUE053974T2 (hu)
MX (1) MX376622B (hu)
MY (1) MY193529A (hu)
PL (1) PL3313370T3 (hu)
RU (1) RU2734344C2 (hu)
WO (1) WO2016207340A1 (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307158B6 (cs) * 2016-12-23 2018-02-07 Contipro A.S. Oftalmologický prostředek
KR102090736B1 (ko) * 2018-05-18 2020-04-23 서울대학교산학협력단 담체 복합체 및 이를 포함하는 약학 조성물
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof
KR20240040272A (ko) * 2022-09-21 2024-03-28 동국대학교 산학협력단 약물을 담지한 동결건조 히알루론산을 포함하는 점막 투여용 약물 전달체

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075527A (en) * 1960-06-02 1963-01-29 Chemway Corp Sterile medicated strips
CA1311686C (en) * 1986-06-25 1992-12-22 John Weldon Shell Controlled release bioerodible drug delivery system
DE69840495D1 (de) * 1997-02-20 2009-03-12 Massachusetts Inst Technology Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben
FR2833493B1 (fr) * 2001-12-18 2005-09-23 Ioltechnologie Production Forme galenique solide et soluble pour l'administration occulaire de principes actifs et procede de fabrication d'un insert ophtalmique solide et soluble
CN1671400A (zh) * 2002-07-03 2005-09-21 派瑞克科学公司 透明质酸组合物以及使用方法
MXPA03011987A (es) * 2003-12-19 2005-06-23 Osio Sancho Alberto Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal.
US7323425B2 (en) * 2004-08-27 2008-01-29 Stony Brook Technology And Applied Research Crosslinking of hyaluronan solutions and nanofiberous membranes made therefrom
TW200612991A (en) 2004-09-07 2006-05-01 Chugai Pharmaceutical Co Ltd Process for producing water-soluble hyaluronic acid modification
CN1757414A (zh) * 2005-09-09 2006-04-12 中国海洋大学 一种治疗眼表疾病的载药可视多糖膜片的制造方法
US8979931B2 (en) * 2006-12-08 2015-03-17 DePuy Synthes Products, LLC Nucleus replacement device and method
US20130136784A1 (en) * 2007-10-11 2013-05-30 Robert J. Staab Methods for delivery of medication using dissolvable devices
US20110229551A1 (en) * 2010-03-17 2011-09-22 Notus Laboratories, Inc. Drug delivery compositions and methods using nanofiber webs
RU2458709C1 (ru) * 2010-12-28 2012-08-20 Общество с ограниченной ответственностью "НПО ЛИОМАТРИКС" Биопластический материал
CZ302994B6 (cs) * 2010-12-31 2012-02-08 Cpn S.R.O. Hyaluronová vlákna, zpusob jejich prípravy a použití
WO2013171764A2 (en) * 2012-04-30 2013-11-21 Rubicon Research Private Limited Ophthalmic formulations

Also Published As

Publication number Publication date
WO2016207340A1 (en) 2016-12-29
MY193529A (en) 2022-10-18
KR20180021065A (ko) 2018-02-28
ES2864638T3 (es) 2021-10-14
EP3108874A1 (en) 2016-12-28
PL3313370T3 (pl) 2021-10-25
RU2018102746A3 (hu) 2019-11-29
US20180296473A1 (en) 2018-10-18
MX2017016439A (es) 2018-08-16
RU2018102746A (ru) 2019-07-29
JP2018518514A (ja) 2018-07-12
JP6918711B2 (ja) 2021-08-11
DK3313370T3 (da) 2021-03-29
EP3313370A1 (en) 2018-05-02
EP3313370B1 (en) 2020-12-30
RU2734344C2 (ru) 2020-10-15
MX376622B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
HUE058677T2 (hu) Meloxicamot tartalmazó gyógyászati készítmény
DK3328880T3 (da) Terapeutiske midler
DK3722274T3 (da) 2-perfluorbutylpentan til oftalmisk indgivelse
HUE054344T2 (hu) Gyógyászati készítmények AZD9291 tartalommal
PT4070788T (pt) Formulações farmacêuticas
EP3424940A4 (en) Radiolabeled drug
DK3199161T3 (da) Farmaceutisk præparat
EP3246047C0 (en) COMBINATION MEDICATION
EP3437644A4 (en) MEDICINE
BR112016026078A2 (pt) Produto absorvente
DK3280447T3 (da) Farmaceutiske formuleringer
HUE053974T2 (hu) Szemészeti gyógyászati készítmény
EP3527216A4 (en) Medicine
EP3305294A4 (en) AQUEOUS MEDICINE
EP3395344A4 (en) MEDICINE
DK3288967T3 (da) Farmaceutisk forbindelse
EP3217965C0 (en) Pharmaceutical processing
HUE050881T2 (hu) Gyógyszerkészítmény
DK3307076T3 (da) Podepartikelprodukt
HUE057830T2 (hu) Famitinib tartalmú gyógyszerkészítmény
DK3288966T3 (da) Farmaceutisk forbindelse
BR112018009951A2 (pt) fármaco oftálmico
UA32221S (uk) Пляшечка на ліки
ITUB20156017A1 (it) Collirio oftalmico
TH1501007302A (th) ยาเตรียมทางเภสัชกรรม